Control of blood glucose (BG) in an acceptable range is a major therapy target for diabetes patients in both the hospital and outpatient environments. This review focuses on the state of point-of-care (POC) glucose monitoring and the accuracy of the measurement devices. The accuracy of the POC glucose monitor depends on device methodology and other factors, including sample source and collection and patient characteristics. Patient parameters capable of influencing measurements include variations in pH, blood oxygen, hematocrit, changes in microcirculation, and vasopressor therapy. These elements alone or when combined can significantly impact BG measurement accuracy with POC glucose monitoring devices (POCGMDs). In general, currently available POCGMDs exhibit the greatest accuracy within the range of physiological glucose levels but become less reliable at the lower and higher ranges of BG levels. This issue raises serious safety concerns and the importance of understanding the limitations of POCGMDs. This review will discuss potential interferences and shortcomings of the current POCGMDs and stress when these may impact the reliability of POCGMDs for clinical decision-making.
CowieCCRustKFFordESEberhardtMSByrd-HoltDDLiCWilliamsDEGreggEWBainbridgeKESaydahSHGeissLS. Full accounting of diabetes and pre-diabetes in the U.S. population in 1988–1994 and 2005–2006. Diabetes Care.2009; 32 (2): 287–94.
2.
SacksDBBrunsDEGoldsteinDEMacLarenNKMcDonaldJMParrottM. Guidelines and recommendations for laboratory analysis in the diagnosis and management of diabetes mellitus. Clin Chem.2002; 48 (3): 436–72.
3.
AlterDDeinesG. Tight glycemic control and point-of-care testing. Clin Lab Med.2009; 29 (3): 511–22.
4.
FahyBGSheehyAMCoursinDB. Glucose control in the intensive care unit. Crit Care Med.2009; 37 (5): 1769–76.
5.
PitkinADRiceMJ. Challenges to glycemic measurement in the perioperative and critically ill patient: A review. J Diabetes Sci Technol.2009; 3 (6): 1270–81.
6.
Van den BergheGWoutersPWeekersFVerwaestCBruyninckxFSchetzMVlasselaersDFerdinandePLauwersPBouillonR. Intensive insulin therapy in critically ill patients. N Engl J Med.2001; 345 (19): 1359–67.
7.
Van den BergheGWilmerAHermansGMeerssemanWWoutersPJMilantsIVan WijngaerdenEBobbaersHBouillonR. Intensive insulin therapy in the medical ICU. N Engl J Med.2006; 354 (5): 449–61.
8.
BergelASouppeJComtatM. Enzymatic amplification for spectrophotometric and electrochemical assays of NAD+ and NADH. Anal Biochem.1989; 179 (2): 382–8.
9.
TangZLouieRFPayesMChangKCKostGJ. Oxygen effects on glucose measurements with a reference analyzer and three handheld meters. Diabetes Technol Ther.2000; 2 (3): 349–62.
10.
TangZDuXLouieRFKostGJ. Effects of pH on glucose measurements with handheld glucose meters and a portable glucose analyzer for point-of-care testing. Arch Pathol Lab Med.2000; 124 (4): 577–82.
11.
TangZLouieRFLeeJHLeeDMMillerEEKostGJ. Oxygen effects on glucose dehydrogenase- and oxidase-based test strips for point-of-care testing. Crit Care Med.2001; 29 (5): 1062–70.
12.
RiceMJPitkinADCoursinDB. Glucose measurement in the operating room: More complicated than it seems. Anesth Analg.2010; 110 (4): 1056–65.
TangZDuXLouieRFKostGJ. Effects of drugs on glucose measurements with handheld glucose meters and a portable glucose analyzer. Am J Clin Pathol.2000; 113 (1): 75–86.
16.
KaronBSGriesmannLScottRBryantSCDuboisJAShireyTLPrestiSSantrachPJ. Evaluation of the impact of hematocrit and other interference on the accuracy of hospital-based glucose meters. Diabetes Technol Ther.2008; 10 (2): 111–20.
17.
HowertonDKrolakJMManasterskiAHandsfieldJH. Proficiency testing performance in US laboratories: Results reported to the Center for Medicare and Medicaid Services, 1994 through 2006. Arch Pathol Lab Med.2010; 134 (5): 751–8.
18.
MillerWGMyresGLAshwoodERKilleenAAWangEEhlersGWHassemerDLoSFSeccombeDSiekmannLThienpontLMTothA. State of the art in trueness and interlaboratory harmonization for 10 analytes in general clinical chemistry. Arch Pathol Lab Med.2008; 132 (5): 838–46.
19.
ArabadjiefDNicholsJH. Assessing glucose meter accuracy. Curr Med Res Opin.2006; 22 (11): 2167–74.
20.
TonyushkinaKNicholsJH. Glucose meters: A review of technical challenges to obtaining accurate results. J Diabetes Sci Technol.2009; 3 (4): 971–80.
21.
D'OrazioPBurnettRWFogh-AndersonNJacobsEKuwaKKülpmannWRLarssonLLewenstamAMaasAHMagerGNaskalskiJWOkoroduduAO; IFCC-SD-WG-SEPOCT. Approved IFCC recommendation on reporting results for blood glucose: International Federation of Clinical Chemistry and Laboratory Medicine Scientific Division, Working Group on Selective Electrodes and Point-of-Care Testing (IFCC-SD-WG-SEPOCT). Clin Chem Lab Med.2006; 44 (12): 1486–90.
22.
AtkinSHDasmahapatraAJakerMChorostMIReddyS. Fingerstick glucose determination in shock. Ann Intern Med.1991; 114 (12): 1020–4.
23.
KilpatrickESRumleyAGSmithEA. Variation in sample pH and pO2 affect ExacTech meter glucose measurements. Diabet Med.1994; 11 (5): 506–9.
KrouwerJSCembrowskiGS. A review of standards and statistics used to describe blood glucose monitor performance. J Diabetes Sci Technol.2010; 4 (1): 75–83.
28.
American Diabetes Association (ADA).Consensus statement on self-monitoring of blood glucose. Diabetes Care.1987; 10 (1): 93–9.
29.
American Diabetes Association.Self-monitoring of blood glucose: Clinical practice recommendations. Diabetes Care.1996; 19: S62–6.
30.
American Diabetes Association.Standards of medical care in diabetes—2008. Diabetes Care.2008; 31Suppl 1: S12–54.
31.
International Organization for Standardization: ISO 15197.In vitro diagnostic test systems—requirements for blood glucose monitoring systems for self-testing in managing diabetes mellitus. Geneva: International Organization for Standardization, 2003.
ClarkeWLCoxDGonder-FrederickLACarterWPohlSL. Evaluating clinical accuracy of systems for self-monitoring of blood glucose. Diabetes Care.1987; 10 (5): 622–8.
37.
ParkesJLSlatinSLPardoSGinsbergBH. A new consensus error grid to evaluate the clinical significance of inaccuracies in the measurement of blood glucose. Diabetes Care.2000; 23 (8): 1143–8.
38.
GiordanoBPHodgesCTrashWDubeWPHodgesCSwainABanionCRKlingensmithGJ. Performance of seven blood glucose testing systems at high altitude. Diabetes Educ.1989; 15 (5): 444–8.
CohenMBoyleEDelaneyCShawJ. A comparison of blood glucose meters in Australia. Diabetes Res Clin Pract.2006; 71 (2): 113–8.
41.
KhanAIVasquezYGrayJWiansFHJrKrollMH. The variability of the results between point-of-care testing glucose meters and the central laboratory analyzer. Arch Pathol Lab Med.2006; 130 (10): 1527–32.
42.
ThomasLEKaneMPBakstGBuschRSHamiltonRAAbelsethJM. A glucose meter accuracy and precision comparison: The FreeStyle Flash versus the Accu-Chek Advantage, Accu-Chek Compact Plus, Ascensia Contour, and the BD Logic. Diabetes Technol Ther.2008; 10 (2): 102–10.
43.
SheffieldCAKaneMPBakstGBuschRSAbelsethJMHamiltonRA. Accuracy and precision of four value-added blood glucose meters: The Abbott Optium, the DDI Prodigy, the HDI True Track, and the HypoGuard Assure Pro. Diabetes Technol Ther.2009; 11 (9): 587–92.
44.
FlorkowskiCBudgenCKendallDLuntHMooreMP. Comparison of blood glucose meters in a New Zealand diabetes centre. Ann Clin Biochem.2009; 46 (Pt 4): 302–5.
45.
The Diabetes Research in Children Network (DIRECNET) Research Group.A multicenter study of the accuracy of the One Touch Ultra home glucose meter in children with type I diabetes. Diabetes Technol Ther.2003; 5 (6): 933–41.
46.
StorkADKempermanHErkelensDWVenemanTF. Comparison of the accuracy of the HemoCue glucose analyzer with the Yellow Springs Instrument glucose oxidase analyzer, particularly in hypoglycemia. Eur J Endocrinol.2005; 153 (2): 275–81.
47.
RosenthalMUgeleBLipowskyGKüsterH. The Accutrend sensor glucose analyzer may not be adequate in bedside testing for neonatal hypoglycemia. Eur J Pediatr.2006; 165 (2): 99–107.
48.
RiversSMKaneMPBakstGBuschRSHamiltonRA. Precision and accuracy of two glucose meters: FreeStyleFlash versus OneTouch Ultra. Am J Health-Syst Pharm.2006; 63 (15): 1411–16.
49.
LippiGSalvagnoGLGuidiGCNegriMRizzatiP. Evaluation of four portable self-monitoring blood glucose meters. Ann Clin Biochem.2006; 43 (Pt 5): 408–13.
50.
BelliniCSerraGRissoDMazzellaMBonioliE. Reliability assessment of glucose measurement by HemoCue analyser in a neonatal intensive care unit. Clin Chem Lab Med.2007; 45 (11): 1549–54.
51.
AshworthLGibbIAlbertiKG. HemoCue: Evaluation of a portable photometric system for determining glucose in whole blood. Clin Chem.1992; 38 (8 Pt 1): 1479–82.
52.
WienerK. An assessment of the effect of haematocrit on the HemoCue blood glucose analyzer. Ann Clin Biochem.1993; 30 (Pt 1): 90–3.
53.
LarbigMForstTMondokAForstSPfütznerA. Investigation on the accuracy of the blood glucose monitoring device Prestige IQ. Diabetes Nutr Metab.2003; 16 (4): 257–61.
54.
SinghDGAgarwalMBishawiB. Evaluation of a glucose meter against analytical quality specifications for hospital use. Clin Chim Acta.2004; 343 (1–2): 217–21.
55.
DaiKSTaiDYHoPChenCCPengWCChenSTHsuCCLiuYPHsiehHCYangCCTsaiMCMaoSJ. Accuracy of the EasyTouch blood glucose self-monitoring system: A study of 516 cases. Clin Chim Acta.2004; 349 (1–2): 135–41.
56.
KendallDMKaplanRAPaulsonCFParksJLTidemanAM. Accuracy and utility of a 10-test disk blood glucose meter. Diabetes Res Clin Pract.2005; 67 (1): 29–35.
57.
RaoLVJakubiakFSidwellJSWinklemanJWSnyderML. Accuracy evaluation of a new glucometer with automated hematocrit measurement and correction. Clin Chim Acta.2005; 356 (1–2): 178–83.
58.
HawkinsRC. Evaluation of Roche Accu-Chek Go and Medisense Optium blood glucose meters. Clin Chim Acta.2005; 353 (1–2): 127–31.
59.
NICE-SUGAR Study Investigators; FinferSChittockDRSuSYBlairDFosterDDhingraVBellomoRCookDDodekPHendersonWRHébertPCHeritierSHeylandDKMcArthurCMcDonaldEMitchellIMyburghJANortonRPotterJRobinsonBGRoncoJJ. Intensive versus conventional glucose control in critically ill patients. N Engl J Med.2009; 360 (13): 1283–97.
60.
MoghissiESKorytowskiMTDiNardoMEinhornDHellmanRHirschIBInzucchiSEIsmail-BeigiFKirkmanMSUmpierrezGE; American Association of Clinical Endocrinologists; American Diabetes Association. American Association of Clinical Endocrinologists and American Diabetes Association Consensus statement on inpatient glycemic control. Endocr Pract.2009; 15 (4): 353–69.
61.
MaserREButlerMADeCherneyGS. Use of arterial blood with bedside glucose reflectance meters in an intensive care unit: Are they accurate?. Crit Care Med.1994; 22 (4): 595–9.
62.
LouieRFTangZSuttonDVLeeJHKostGJ. Point-of-care glucose testing: Effects of critical care variables, influence of reference instruments, and a modular glucose meter design. Arch Pathol Lab Med.2000; 124 (2): 257–66.
63.
LacaraTDomagtoyCLickliterDQuattrocchiKSnipesLKuszajJPrasnikarM. Comparison of point-of-care and laboratory glucose analysis in critically ill patients. Am J Crit Care.2007; 16 (4): 336–46.
64.
CookALaughlinDMooreMNorthDWilkinsKWongGWallace-ScroggsAHalvorsenL. Differences in glucose values obtained from point-of-care glucose meters and laboratory analysis in critically ill patients. Am J Crit Care.2009; 18 (1): 65–72.
65.
MushholtPBSchipperCThoméNRamljakSSchmidtMForstTPfütznerA. Dynamic electrochemistry corrects for hematocrit interference on blood glucose determinations with patient self-measurement devices. J Diabetes Sci Technol.2011; 5 (5): 1167–75.
66.
RiceMJ. Dynamic electrochemistry: A step in the right direction. J Diabetes Sci Technol.2011; 5 (5): 1176–8.
67.
WuPMoreyTEHarrisNSGravensteinNRiceMJ. Intravenous fluids cause systemic bias in a conductivity-based point-of-care hematocrit meter. Anesth Analg.2011. Epub, PMID 22156329.
68.
KanjiSBuffieJHuttonBBuntingPSSinghAMcDonaldKFergussonDMcIntyreLAHebertPC. Reliability of point-of-care testing for glucose measurement in critically ill adults. Crit Care Med.2005; 33 (12): 2778–85.
69.
FinkielmanJDOyenLJAfessaB. Agreement between bedside blood and plasma glucose measurement in the ICU setting. Chest.2005; 127 (5): 49–51.
70.
Slater-MacleanLCembrowskiGShalapayCBinetteTHegadorenKNewburn-CookC. Accuracy of glycemic measurements in the critically ill. Diabetes Technol Ther.2008; 10 (3): 169–77.
71.
DesachyAVuagnatACGhazaliADBaudinOTLonguetOHCalvatSNGissotV. Accuracy of bedside glucometry in critically ill patients: Influence of clinical characteristics and perfusion index. Mayo Clin Proc.2008; 83 (4): 400–5.
72.
HassenM FekihAyedSGharbiRAliH Ben SikMarghliSElatrousS. Bedside capillary blood glucose measurements in critically ill patients: Influence of catecholamine therapy. Diabetes Res Clin Pract.2010; 87 (1): 87–91.
73.
SylvainHFPokornyMEEnglishSMBensonNHWhitleyTWFerenczyCJHarrisonJG. Accuracy of fingerstick glucose values in shock patients. Am J Crit Care.1995; 4 (1): 44–8.
74.
StoutPJPeledNEricksonBJHilgersMERacchiniJRHoeghTB. Comparison of glucose levels in dermal interstitial fluid and finger capillary blood. Diabetes Technol Ther.2001; 3 (1): 81–90.
75.
RayJGHamielecCMastracciT. Pilot study of the accuracy of bedside glucometry in the intensive care unit. Crit Care Med.2001; 29 (11): 2205–7.
76.
KaronBSGandhiGYNuttallGABryantSCSchaffHVMcMahonMMSantrachPJ. Accuracy of Roche Accu-Chek inform whole blood capillary, arterial, and venous glucose values in patients receiving intensive intravenous insulin therapy after cardiac surgery. Am J Clin Pathol.2007; 127 (6): 919–26.
77.
CritchellCDSavareseVCallahanAAboudCJabbourSMarikP. Accuracy of bedside capillary blood glucose measurements in critically ill patients. Intensive Care Med.2007; 33 (12): 2076–84.
78.
HoedemaekersCWGunnewiekJM KleinPrinsenMAWillemsJLVan der HoevenJG. Accuracy of bedside glucose measurement from three glucometers in critically ill patients. Crit Care Med.2008; 36 (11): 3062–6.
79.
PetersenJRGravesDFTackerDHOkoroduduAOMohammadAACardenasVJJr. Comparison of POCT and central laboratory blood glucose results using arterial, capillary, and venous samples from MICU patients on a tight glycemic protocol. Clin Chim Acta.2008; 396 (1–2): 10–13.
80.
MeynaarLAvan SpreuwelMTangkauPLDawsonLVisserS SleeswijkRijksLVlielandTV. Accuracy of AccuChek glucose measurement in intensive care patients. Crit Care Med.2009; 37 (10): 2691–6.
81.
KaronBSBoydJCKleeGG. Glucose meter performance criteria for tight glycemic control estimated by simulation modeling. Clin Chem.2010; 56 (7): 1091–7.
82.
JaxTHeiseTNosekLGableJLimGCalentineC. Automated near-continuous glucose monitoring measured in plasma using mid-infrared spectroscopy. J Diabetes Sci Technol.2011; 5 (2): 345–52.
83.
VaddirajuSBurgessDJTomazosIJainFCPapadimitrakopoulosF. Technology for continuous glucose monitoring: Current problems and future promises. J Diabetes Sci Technol.2010; 4 (6): 1540–62.
